Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rnaNGS
    Member
    • Dec 2009
    • 44

    #1

    RNA Modification Database and The Map of RNA Modifications

    We have developed RMBase v2.0 to decode the map of RNA modifications (>100 different modification types) , as well as their relationships with microRNA binding events, disease-related SNPs or variations and RNA-binding proteins (RBP).

    RMBase v2.0 was expanded with ~1402760 modification sites identified from 566 high-throughput epitranscriptome sequencing data (m1A-seq, Pseudo-seq, Ψ-seq, CeU-seq, Aza-IP, MeRIP-seq, m6A-seq, miCLIP, m6A-CLIP, RiboMeth-seq, Nm-seq) and public modification databases. It represented about 10 times expansion when compared to the previous release.

    It contains ~1 379 400 N6-Methyladenosines (m6A), ~4 900 N1-Methyladenosines (m1A), ~9 600 pseudouridine (Ψ) modifications, ~1 000 5-methylcytosine (m5C) modifications, ~5 100 2′-O-methylations (2′-O-Me), and ~2 800 modifications of 100 other types.

    We developed “Motif” module to provide both de novo identified position weight matrices (PWMs) and visualized logos of modification motifs.

    We developed “modRBP” module to analyze the relationships of RNA modifications and RNA-binding Protein (RBP).

    We developed a novel web-based tool named "modMetagene" for plotting metagenes of RNA modifications along a transcript model.

    We developed modSNV and modSNP to decode the relationships between RNA modifications (m6A, m5C, 2′-O-Me) and variations (SNV, SNP), and link them to human cancers and other diseases.

    RMBase v2.0 is freely available at http://rna.sysu.edu.cn/rmbase/.

    Last edited by rnaNGS; 08-28-2017, 02:28 AM. Reason: add figure

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...